Preparation of an Attenuated Dengue 4 (341750 Carib) Virus Vaccine

II. Safety and Immunogenicity in Humans

Charles H. Hoke Jr. Walter Reed Army Institute of Research, U.S. Army Research Institute of Infectious Diseases, Washington, DC

Search for other papers by Charles H. Hoke Jr. in
Current site
Google Scholar
PubMed
Close
,
Frank J. Malinoski Walter Reed Army Institute of Research, U.S. Army Research Institute of Infectious Diseases, Washington, DC

Search for other papers by Frank J. Malinoski in
Current site
Google Scholar
PubMed
Close
,
Kenneth H. Eckels Walter Reed Army Institute of Research, U.S. Army Research Institute of Infectious Diseases, Washington, DC

Search for other papers by Kenneth H. Eckels in
Current site
Google Scholar
PubMed
Close
,
Robert McNair Scott Walter Reed Army Institute of Research, U.S. Army Research Institute of Infectious Diseases, Washington, DC

Search for other papers by Robert McNair Scott in
Current site
Google Scholar
PubMed
Close
,
Doria R. Dubois Walter Reed Army Institute of Research, U.S. Army Research Institute of Infectious Diseases, Washington, DC

Search for other papers by Doria R. Dubois in
Current site
Google Scholar
PubMed
Close
,
Peter L. Summers Walter Reed Army Institute of Research, U.S. Army Research Institute of Infectious Diseases, Washington, DC

Search for other papers by Peter L. Summers in
Current site
Google Scholar
PubMed
Close
,
Thomas Simms Walter Reed Army Institute of Research, U.S. Army Research Institute of Infectious Diseases, Washington, DC

Search for other papers by Thomas Simms in
Current site
Google Scholar
PubMed
Close
,
Jeanne Burrous Walter Reed Army Institute of Research, U.S. Army Research Institute of Infectious Diseases, Washington, DC

Search for other papers by Jeanne Burrous in
Current site
Google Scholar
PubMed
Close
,
Sherman E. Hasty Walter Reed Army Institute of Research, U.S. Army Research Institute of Infectious Diseases, Washington, DC

Search for other papers by Sherman E. Hasty in
Current site
Google Scholar
PubMed
Close
, and
William H. Bancroft Walter Reed Army Institute of Research, U.S. Army Research Institute of Infectious Diseases, Washington, DC

Search for other papers by William H. Bancroft in
Current site
Google Scholar
PubMed
Close
Restricted access

To determine safety and immunogenicity, a single 0.5 ml dose of a monovalent live-attenuated dengue (DEN) 4 (341750 Carib) vaccine was given sc to 3 groups of flavivirus nonimmune volunteers in increasing concentrations. Two recipients received 103 plaque forming units (PFU)/dose (1:100 dilution of stock vaccine). One remained asymptomatic, but became viremic between days 12 and 15, experienced a mild elevation of temperature (37.4°C), and developed DEN-4 specific antibody. Neither recipient of the 104 PFU became infected. Eight volunteers then received undiluted vaccine (105 PFU). Viremia and antibody (neutralizing, hemagglutination inhibition, and IgM) developed in 5 of the 8 (63%). These 5 volunteers also developed a scarcely noticeable macular, blanching rash and minimal temperature elevations (37.3, 38.1, 37, 37.9, and 37.9°C). Clinically insignificant decreases in total white blood cell, lymphocyte, and polymorphonuclear cell counts and an elevation in mononuclear cell counts occurred in association with viremia. This vaccine is safe, reasonably immunogenic, and suitable for further evaluation.

Author Notes

Save